Resource Center
Resource Center
National HIV treatment programs are preparing for big shifts in their national treatment guidelines and patient regimens. The World Health Organization’s (WHO) 2016 guidelines included a number of antiretroviral (ARV) medications that are more effective, tolerable and affordable (some of which are now available), in addition to optimal pediatric formulations which improve upon limited treatment...
Read moreLondon, 30 November 2016 – UNITAID and the Clinton Health Access Initiative (CHAI) today announced a three-year project to speed the introduction of new, optimal HIV drugs, and make them more available and affordable. The US$34 million investment is expected to be a boon for adults and children living with HIV who receive treatments that...
Read moreSixteen years ago, the 13th International AIDS Conference (IAS) convened in Durban, South Africa, to “break the silence” on the millions of preventable AIDS-related deaths occurring around the world. The summit was notable as it laid out the clear case that HIV causes AIDS, allowed people living with HIV/AIDS (PLWHA)’s voices to be heard, and...
Read moreCHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretrovirals (ARVs) on behalf of members of its procurement consortium. See the 2015 CHAI ARV Reference Price List here.
Read moreIn 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2015 Family Planning Market Report can be found below.
Read moreCHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS.
Read moreCHAI's ARV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2013 and outlines CHAI's expectations on how this market will evolve over the next five years.
Read more